Authors
Latest:
Precision medicine in diabetic macular edema: Expert consensus on the efficacy and safety of the 0.19-mg fluocinolone acetonide implantResults from expert surveys provide snapshots of our understanding of DME and shed light on where the 0.19-mg FAc implant stands in the current standard of care.
Latest:
Dexamethasone rebuttal: Who should perform intravitreal injections?In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.
Latest:
Sustained drug delivery in ophthalmologyCurrent options, challenges in developing novel therapies.
Latest:
Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic AtrophyA retina specialist shares his presentation from the 2023 ASRS Annual Meeting, which describes a study comparing the efficacy of 2 FDA-approved treatments for geographic atrophy based on an anchored matching-adjusted indirect comparison of phase 3 trial findings.
Latest:
FDA issues CRL for aflibercept 8 mg from Regeneron PharmaceuticalsThe company announced the Complete Letter Response from the FDA for the Biologics License Application for aflibercept 8 mg is “solely due to an ongoing review of inspection findings at a third-party filler.”
Latest:
Key Retreatment Decisions in the Clinical Trials for Faricimab in nAMDDr Varun Chaudhary presents the retreatment decisions during the treat-and-extend phase of the TENAYA and LUCERNE clinical trials in neovascular AMD, focusing on the percentage of patients who maintained, extended, or reduced their treatment interval based on visual and anatomic criteria.
Latest:
UNCOVERING HIDDEN PREDATORS IN DISEASEThis article is produced by Roche for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.
Latest:
Natural language processing helps ophthalmologists access data, improves data curationKnowledge of tools used in data interpretation helps clinicians trust accuracy of findings.
Latest:
Successful ocular surgery in patients with chronic uveitisWhile operating on a patient with chronic uveitis presents some challenges, there are a few pearls that may increase success.
Latest:
Promoting Treatment Adherence in nAMD and DMEExperts conclude the series with the hope that longer-acting agents will lead to better real-world outcomes for patients, mirroring clinical trial results and potentially preventing vision loss, especially in countries with limited access to healthcare.
Latest:
Is complement therapy the path forward for geographic atrophy?Clinical benefit of complement inhibition has been demonstrated in clinical trials, but there are possible consequences to consider.
Latest:
FDA approves clobetasol propionate ophthalmic suspension 0.05% from Formosa Pharmaceuticals and AimMax TherapeuticsThe approval marks the first new steroid on the ophthalmic market in more than 15 years.
Latest:
Adapting medical retina service in COVID-19 era requires careful approachMinimizing clinic visits, maximizing use of imaging modalities are key
Latest:
ABVC BioPharma announces approved plan for pilot Good Manufacturing Practice (GMP) facility to produce VitargusThe plan is intended to upgrade Vitagrus’ manufacturing process so that it can ultimately handle the global market supply.
Latest:
Successful treatment of bilateral diffuse Uveal melanocytic proliueration with plasmapheresisNonetheless,BDUMP remains a rare condition with fewer than 60 cases documented in literature.
Latest:
Ultra-widefield imaging: A critical step in uveitis diagnosis and managementA multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.
Latest:
Q&A: The increasing potential of ERG in diagnosing a wide range of eye conditionsEasier, more accessible functional studies have been made possible
Latest:
Humanity + technology: Talking to patients about the science and benefits of clinical trialsWhen we discuss trial participation with patients, we stress that the goal of these studies is to obtain better visual outcomes and ease the treatment burden.
Latest:
COVID-19 pandemic highlights the power of electronic health recordsElectronic health records may be the future of practice management.
Latest:
ARVO 2024: Daniel Saban, PhD, on the Cogan Lecture 2024At this year's ARVO meeting, the Eye Care Network spoke with Daniel Saben PhD, who is being awarded the Cogan Lecture at this year's event.
Latest:
ARVO 2024: Daniel Saban, PhD, on the Cogan Lecture 2024At this year's ARVO meeting, the Eye Care Network spoke with Daniel Saben PhD, who is being awarded the Cogan Lecture at this year's event.
Latest:
High-resolution multimodal imaging is key in dry AMD therapeutic development, future managementIn an attempt to halt the progression of dry AMD and geographic atrophy, the use of high-resolution optical coherence tomography becomes pivotal.
Latest:
Effectiveness Of Pegcetacoplan In Preserving Visual Function In Geographic AtrophyDr Charles Wykoff presents the results of a post hoc microperimetry analysis from the OAKS study demonstrating the effectiveness of pegcetacoplan in preserving visual function.
Latest:
Clinical Implications of Port Delivery System in Retinal DiseasesClosing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.
Latest:
Vitrectomy: Is higher speed always better?Physicians should consider hydrodynamic cavitation when performing this procedure.
Latest:
Poll: Most anticipated emerging therapies in neovascular AMD and DMEA panel of retina specialists review new and emerging treatments in neovascular AMD and DME, highlighting high-dose aflibercept and KSI-301. Which emerging treatments are you most interested in?
